PROM1 and neoplasm: More importantly, the TAT‐strep‐CD133(848–865) peptide reduced the tumor‐initiating capacity of GSCs (Figure S5P, Supporting Information), and increased the survival of tumor‐bearing mice (Figure 5H and Figure S5Q, Supporting Information).